Correction: A Tissue Factor-Cascade-targeted Strategy to Tumor Vasculature: a Combination of EGFP-EGF1 Conjugation Nanoparticles with Photodynamic Therapy

Wei Shi,Yanxue Yin,Yao Wang,Bo Zhang,Pei Tan,Ting Jiang,Heng Mei,Jun Deng,Huafang Wang,Tao Guo,Zhiqing Pang,Yu Hu

DOI: https://doi.org/10.18632/oncotarget.25079

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.12922.].

What problem does this paper attempt to address?

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Xia Li,Xiufeng Yin,Huafeng Wang,Jiansong Huang,Mengxia Yu,Zhixin Ma,Chenying Li,Yile Zhou,Xiao Yan,ShuJuan Huang,Jie Jin

DOI: https://doi.org/10.18632/oncotarget.27310

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14463.].
Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Ru Zhou,Mahboubeh Yazdanifar,Lopamudra Das Roy,Lynsey M. Whilding,Artemis Gavrill,John Maher,Pinku Mukherjee

DOI: https://doi.org/10.3389/fimmu.2020.628776

IF: 7.3

2020-12-07

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2019.01149.].

immunology
A Tissue Factor-Cascade-targeted Strategy to Tumor Vasculature: a Combination of EGFP-EGF1 Conjugation Nanoparticles with Photodynamic Therapy.

Wei Shi,Yanxue Yin,Yao Wang,Bo Zhang,Pei Tan,Ting Jiang,Heng Mei,Jun Deng,Huafang Wang,Tao Guo,Zhiqing Pang,Yu Hu

DOI: https://doi.org/10.18632/oncotarget.12922

2016-01-01

Oncotarget

Abstract:Tumor requires tumor vasculature to supply oxygen and nutrients so as to support its continued growth, as well as provide a main route for metastatic spread. In this study, a TF-cascade-targeted strategy aiming to disrupt tumor blood vessels was developed by combination of TF-targeted HMME-loaded drug delivery system and PDT. PDT is a promising new modality in the treatment of cancers, which employs the interaction between a tumor-localizing photosensitizer and light of an appropriate wavelength to bring about ROS-induced cell death. In vitro results showed that protein EGFP-EGF1modification could significantly contribute to the uptake of nanoparticles by TF over-expressed BCECs. In vivo multispectral fluorescent imaging, the EGFP-EGF1 conjugated nanoparticles showed significantly higher accumulation in tumor tissues than non-conjugated ones. Tumor tissue slides further presented that EGFP-EGF1 conjugated nanoparticles showed significantly higher accumulation in tumor vasculature than non-conjugated ones. In vitro study demonstrated that PDT increased TF expression of BCECs. In vivo imaging, ex vivo imaging and tumor tissue slides showed that PDT further contribute EGFP-EGF1-NP accumulation in tumor. These promising results indicated that PDT enhanced EGFP-EGF1modified PEG-PLGA nanoparticle accumulation in tumor vaculature. Considering that EGFP-EGF1 conjugation enhanced nanoparticles uptake by TF over-expressed endothelium and PDT increased endothelium TF expression. We conclude that PDT triggered a TF cascade targeted effect. A combination of both EGFP-EGF1 modification and PDT provided a positive feed-back target effect to tumor vessels and might have a great potential for tumor therapy.
Correction: Tumor-targeting, enzyme-activated nanoparticles for simultaneous cancer diagnosis and photodynamic therapy

Huaxia Shi,Wucheng Sun,Changbing Liu,Guiying Gu,Bo Ma,Weili Si,Nina Fu,Qi Zhang,Wei Huang,Xiaochen Dong

DOI: https://doi.org/10.1039/d3tb90090h

IF: 7.571

2023-01-01

Journal of Materials Chemistry B

Abstract:Correction for ‘Tumor-targeting, enzyme-activated nanoparticles for simultaneous cancer diagnosis and photodynamic therapy’ by Huaxia Shi et al. , J. Mater. Chem. B , 2016, 4 , 113–120, https://doi.org/10.1039/C5TB02041G.

materials science, biomaterials
Corrigendum: An in vivo fluorescence resonance energy transfer-based imaging platform for targeted drug discovery and cancer therapy

Fuqiang Xing,Nana Ai,Shigao Huang,Cheng Jiang,Muhammad Jameel Mughal,Wei Ge,Guanyu Wang,Chu-Xia Deng

DOI: https://doi.org/10.3389/fbioe.2022.1039177

IF: 5.7

2022-09-26

Frontiers in Bioengineering and Biotechnology

Abstract:[This corrects the article DOI: 10.3389/fbioe.2022.839078.].

multidisciplinary sciences
Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Hang-Ping Yao,Liang Feng,Sreedhar Reddy Suthe,Ling-Hui Chen,Tian-Hao Weng,Chen-Yu Hu,Eun Sung Jun,Zhi-Gang Wu,Wei-Lin Wang,Song Cheol Kim,Xiang-Min Tong,Ming-Hai Wang

DOI: https://doi.org/10.1186/s40425-019-0571-7

IF: 12.469

2019-01-01

Journal for ImmunoTherapy of Cancer

Abstract:Following publication of the original article [1], the author reported two errors in the authors affiliations:
Combined Photodynamic and Photothermal Therapy and Immunotherapy for Cancer Treatment: A Review [Corrigendum]

Cunqing Kong,Xingcai Chen

DOI: https://doi.org/10.2147/ijn.s422584

IF: 7.033

2023-05-01

International Journal of Nanomedicine

Abstract:[This corrects the article DOI: 10.2147/IJN.S388996.].

pharmacology & pharmacy,nanoscience & nanotechnology
Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA

Qi Chang Zheng,Shuai Jiang,Yu Zhe Wu,Dan Shang,Yong Zhang,Shao Bo Hu,Xiang Cheng,Chen Zhang,Ping Sun,Yang Gao,Zi Fang Song,Min Li

DOI: https://doi.org/10.3389/fbioe.2021.656268

IF: 5.7

2021-02-11

Frontiers in Bioengineering and Biotechnology

Abstract:[This corrects the article DOI: 10.3389/fbioe.2020.00512.].

multidisciplinary sciences
Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Junfeng Zhang,Wei Xue,Kai Xu,Liang Yi,Yu Guo,Tian Xie,Haipeng Tong,Bo Zhou,Shunan Wang,Qing Li,Heng Liu,Xiao Chen,Jingqin Fang,Weiguo Zhang

DOI: https://doi.org/10.7150/thno.92042

IF: 11.6

2023-11-17

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.44427.].
Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Zekun Li,Yongchun Pan,Shizheng Du,Yayao Li,Chao Chen,Hongxiu Song,Yueyao Wu,Xiaowei Luan,Qiang Xu,Xiaoxiang Guan,Yujun Song,Xin Han

DOI: https://doi.org/10.1016/j.apsb.2023.09.002

IF: 14.903

2024-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.016.].
Correction: DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin

Xilin Sun,Lili Yang,Xuefeng Yan,Yingying Sun,Dongliang Zhao,Yang Ji,Kai Wang,Xiaoyuan Chen,Baozhong Shen

DOI: https://doi.org/10.1371/journal.pone.0290861

IF: 3.7

2023-08-25

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0162601.].
Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy: Erratum

Lijun Yang,Donglin Han,Qi Zhan,Xueping Li,Peipei Shan,Yunjie Hu,Han Ding,Yu Wang,Lei Zhang,Yuan Zhang,Sheng Xue,Jin Zhao,Xin Hou,Yin Wang,Peifeng Li,Xubo Yuan,Hongzhao Qi

DOI: https://doi.org/10.7150/thno.55978

IF: 11.6

2021-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.37220.].

medicine, research & experimental
Corrigendum: A Novel Role of Connexin 40-Formed Channels in the Enhanced Efficacy of Photodynamic Therapy

Deng-Pan Wu,Li-Ru Bai,Yan-Fang Lv,Yan Zhou,Chun-Hui Ding,Si-Man Yang,Fan Zhang,Yuan-Yuan Wang,Jin-Lan Huang,Xiao-Xing Yin

DOI: https://doi.org/10.3389/fonc.2022.853278

IF: 4.7

2022-02-23

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00595.].

oncology
Corrigendum: Rational design of a Gd(III)–Cu(II) nanobooster for chemodynamic therapy against cancer cells

Xin-Ya Shi,Ting-Xiao Shen,Ao-Lin Zhang,Li-Tao Tan,Wen-Chang Shen,Hai-Jiang Zhong,Shun-Lin Zhang,Yu-Lan Gu,Lei Shen

DOI: https://doi.org/10.3389/fchem.2022.1075376

IF: 5.5

2022-11-23

Frontiers in Chemistry

Abstract:[This corrects the article DOI: 10.3389/fchem.2022.856495.].

chemistry, multidisciplinary
Correction: Radiopharmaceutical-activated silicon naphthalocyanine nanoparticles towards tumor photodynamic therapy

Tingting Wang,Jingchao Li,Xun Zhang,Chengao Li,Jiang Ming,Jian Li,Dongsheng Zhang,Jun Yang,Nian Liu,Xinhui Su

DOI: https://doi.org/10.1039/d4cc90284j

2024-08-29

Abstract:Correction for 'Radiopharmaceutical-activated silicon naphthalocyanine nanoparticles towards tumor photodynamic therapy' by Tingting Wang et al., Chem. Commun., 2024, https://doi.org/10.1039/d4cc03281k.
Correction to “Folic acid-conjugated liposomal vincristine for multidrug resistant cancer therapy”

Chenyu Wang,Linglin Feng,Xiangkun Yang,Fei Wang,Weiyue Lu

DOI: https://doi.org/10.1016/j.ajps.2022.07.001

IF: 9.273

2022-07-01

Asian Journal of Pharmaceutical Sciences

Abstract:[This corrects the article DOI: 10.1016/j.ajps.2013.07.015.].

pharmacology & pharmacy
Corrigendum: Targeting Myc Interacting Proteins As a Winding Path in Cancer Therapy

Yihui Zhou,Xiaomeng Gao,Yuan Meng,Bo Yang,Qiaojun He,Ji Cao

DOI: https://doi.org/10.3389/fphar.2021.785732

IF: 5.6

2021-01-01

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.748852.].
Correction: FDPP–HA as a theranostic agent for cancer-targeted fluorescence imaging and photodynamic therapy

Pingping Liang,Jinjun Shao,Qianyun Tang,Weili Si,Qiang Wang,Qi Zhang,Xiaochen Dong

DOI: https://doi.org/10.1039/d3ra90050a

IF: 4.036

2023-01-01

RSC Advances

Abstract:Correction for ‘FDPP–HA as a theranostic agent for cancer-targeted fluorescence imaging and photodynamic therapy’ by Pingping Liang et al. , RSC Adv. , 2017, 7 , 37369–37373, https://doi.org/10.1039/C7RA06551E.

chemistry, multidisciplinary
Corrigendum: YY1 Promotes Endothelial Cell-Dependent Tumor Angiogenesis in Hepatocellular Carcinoma by Transcriptionally Activating VEGFA

Wendong Yang,Zhongwei Li,Rong Qin,Xiaorui Wang,Huihui An,Yule Wang,Yan Zhu,Yantao Liu,Shijiao Cai,Shuang Chen,Tao Sun,Jing Meng,Cheng Yang

DOI: https://doi.org/10.3389/fonc.2021.828861

IF: 4.7

2022-01-13

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.01187.].

oncology
Correction: Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer.

Jun-Hui Sun,Tan-Yang Zhou,Yue-Lin Zhang,Guan-Hui Zhou,Chun-Hui Nie,Tong-Yin Zhu,Sheng-Qun Chen,Bao-Quan Wang,Song Ye,Yan Shen,Hua Guo,Wei-Lin Wang,Shu-Sen Zheng

DOI: https://doi.org/10.18632/oncotarget.24759

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14642.].

Correction: A Tissue Factor-Cascade-targeted Strategy to Tumor Vasculature: a Combination of EGFP-EGF1 Conjugation Nanoparticles with Photodynamic Therapy

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

A Tissue Factor-Cascade-targeted Strategy to Tumor Vasculature: a Combination of EGFP-EGF1 Conjugation Nanoparticles with Photodynamic Therapy.

Correction: Tumor-targeting, enzyme-activated nanoparticles for simultaneous cancer diagnosis and photodynamic therapy

Corrigendum: An in vivo fluorescence resonance energy transfer-based imaging platform for targeted drug discovery and cancer therapy

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Combined Photodynamic and Photothermal Therapy and Immunotherapy for Cancer Treatment: A Review [Corrigendum]

Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA

Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Correction: DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin

Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy: Erratum

Corrigendum: A Novel Role of Connexin 40-Formed Channels in the Enhanced Efficacy of Photodynamic Therapy

Corrigendum: Rational design of a Gd(III)–Cu(II) nanobooster for chemodynamic therapy against cancer cells

Correction: Radiopharmaceutical-activated silicon naphthalocyanine nanoparticles towards tumor photodynamic therapy

Correction to “Folic acid-conjugated liposomal vincristine for multidrug resistant cancer therapy”

Corrigendum: Targeting Myc Interacting Proteins As a Winding Path in Cancer Therapy

Correction: FDPP–HA as a theranostic agent for cancer-targeted fluorescence imaging and photodynamic therapy

Corrigendum: YY1 Promotes Endothelial Cell-Dependent Tumor Angiogenesis in Hepatocellular Carcinoma by Transcriptionally Activating VEGFA

Correction: Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer.